title: MRI measures should be a primary outcome endpoint in phase III randomised controlled trials in multiple sclerosis: commentary.
authors.affiliation: Consultant Neurologist, St Vincent's University Hospital, Newman Clinical Research Professor, University College Dublin, Dublin, Ireland.
authors.forename: Michael
authors.initials: M
authors.lastname: Hutchinson
mesh_terms: D006801:Humans; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000473:pathology*; D016032:Randomized Controlled Trials as Topic